Top News
Cavrotolimod Designated Orphan Drug for Merkel Cell Carcinoma
Nivolumab Plus Cabozantinib Tops Sunitinib for Renal Cell Carcinoma
Novel Therapy for Diffuse Intrinsic Pontine Glioma Fast Tracked
Carboplatin Plus Nab-Paclitaxel and RT Promising for Advanced NSCLC in the Elderly
Review Shows Evidence of Link Between Diet, Colorectal Cancer Risk
Keytruda Indication for Metastatic Small Cell Lung Cancer Withdrawn
Cosela Now Available to Reduce Chemotherapy-Induced Bone Marrow Suppression in ES-SCLC
Patient-Reported Outcomes With Lorlatinib in NSCLC
Most Patients With Breast, Ovarian Cancer Patients Do Not Undergo Genetic Testing
Delay in Initiating RT After Chemotherapy in Locally Advanced NSCLC May Shorten DFS
Preexisting Autoimmune Disease Increases Incidence of irAEs With PD-1 Immunotherapy for Advanced Cancer
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
MRI-Based Algorithm Predictive of Biochemical Recurrence After Prostate Cancer Surgery
A retrospective study found that a radiomic-clinicopathologic nomogram performed better than other tools in predicting biochemical recurrence-free survival after surgery for prostate cancer. -
Fact Sheet: COVID-19 Vaccine Considerations for Patients With Cancer
This fact sheet reviews the current guidelines for coronavirus disease 2019 (COVID-19) vaccination in patients with cancer. -
Bariatric Surgery and Colorectal Cancer: Is There a Risk?
C. Andrew Kistler, MD, PharmD, examines existing data about bariatric surgery and the risk for subsequent colorectal cancer development. -
ACE2 Pathway Stimulation Enhances VEGF Inhibition in ccRCC, May Help Overcome VEGF Resistance
New study data offer insight on the mechanisms of angiotensin converting enzyme 2 (ACE2) in clear cell renal cell carcinoma (ccRCC). -
Do Early-Generation TKIs Still Have a Place in EGFR exon 19 or exon 21 L858R-Mutated NSCLC?
A recent wave of approvals has transformed the treatment landscape in non-small cell lung cancer with the most common EGFR mutations— EGFR exon 19 or exon 21 L858R- substitution mutations—giving clinicians a choice between 6 different interventions in the metastatic setting. -
Vitamin D and Pancreatic Cancer: is There a Link?
Vitamin D is a biomarker of interest in the pancreatic cancer setting. -
Data From the CAPTIVATE Study’s uMRD Cohort Suggest Role for Fixed-Duration Therapy in CLL/SLL [Q&A]
John N. Allan, MD, a lead author of the CAPTIVATE study, discusses the findings from the uMRD cohort and their implications for the CLL/SLL paradigm.
More Features
Algorithm Proposed to Expand Cisplatin Eligibility for MIBC
A new algorithm developed by Canadian investigators aims to address underuse of cisplatin-based chemotherapy for muscle-invasive bladder cancer.
American Society of Hematology Releases Updated Guidelines for Treating Newly Diagnosed AML in Older Adults
This review of the guidelines is presented as 6 questions and answers that help direct treatment decision for patients 65 and older with newly diagnosed AML.
Patients Continue to Be Inadequately Informed of Risk for Breast Implant-Associated ALCL
Although the risk for breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) has been well-documented, patients considering breast implants continue to be inadequately informed of the propensity for disease development.
American Cancer Society 2021 Statistics Report Shows Continuous Decline in Cancer Mortality Rate, Illuminates Disease-Specific Trends
The American Cancer Society’s annual report approximates the new cancer diagnoses and deaths expected in 2021 and identifies impactful patterns in oncology care.
Strategies for Patient Comfort, Position Holding, and Compliance During Radiotherapy Treatments
A systematic review of studies focused on strategies to improve patient comfort and compliance with radiotherapy treatment plans, finding that aromatherapy strategies show promise in this setting.
-
Loading...
-
Loading...
